SCHEMBL4984557

SCHEMBL4984557

CC(C)COC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789007 0.79
SCHEMBL8724616 0.77 ALDH1A1 (0.33)
SCHEMBL8908083 0.77 ALDH1A1 (0.33)
SCHEMBL11210735 0.74
SCHEMBL6141173 0.74
SCHEMBL2090540 0.72
SCHEMBL24856 0.71
SCHEMBL634253 0.71
Isopropyl Alcohol SCHEMBL7592214 0.69 ALDH1A1 (0.43)
SCHEMBL12353675 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754607-B Oxadiazole compound and application thereof 沈阳化工大学 2023-09-05 CN claimed
CN-113754607-A Oxadiazole compound and application thereof 沈阳化工大学 2021-12-07 CN claimed
CN-106831638-A 5 substituted thiazole amides compounds and preparation method and application 中国农业大学 2017-06-13 CN claimed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
EP-0000931-B1 ENZYMATIC CLEAVAGE OF N-ACYL-THIENAMYCINS MERCK & CO. INC. (US) 1982-04-14 EP claimed
US-4162193-A Enzymatic cleavage of N-acyl-thienamycins MERCK & CO., INC. (US) 1979-07-24 US claimed
EP-0000931-A1 Enzymatic cleavage of N-acyl-thienamycins MERCK & CO. INC. (US) 1979-03-07 EP claimed
CN-113754607-B Oxadiazole compound and application thereof 沈阳化工大学 2023-09-05 CN disclosed
CN-113754607-A Oxadiazole compound and application thereof 沈阳化工大学 2021-12-07 CN disclosed
CN-106831638-B 5-substituted thiazole amide compounds and preparation method and application thereof 中国农业大学 2020-05-12 CN disclosed
CN-106831638-A 5 substituted thiazole amides compounds and preparation method and application 中国农业大学 2017-06-13 CN disclosed
US-20080114020-A1 such as 7,7-Difluoro-2,3-dimethyl-8-hydroxy-9-phenyl-7H-8,9-dihydro-pyrano(2,3-c]imidazo[1,2-a]pyridine; inhibit gastric acid secretion by blockade of the H+/K+-ATPase; reversible proton pump inhibitors (rPPI's) or acid pump antagonists (APA's) bind reversibly to H+/K+-ATPase; gastrointestinal disorders ALTANA PHARMA AG (DE) 2008-05-15 US disclosed
US-4196291-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1980-04-01 US disclosed
US-4162193-A Enzymatic cleavage of N-acyl-thienamycins MERCK & CO., INC. (US) 1979-07-24 US disclosed
EP-0000931-A1 Enzymatic cleavage of N-acyl-thienamycins MERCK & CO. INC. (US) 1979-03-07 EP disclosed
US-4141978-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1979-02-27 US disclosed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US disclosed
US-4001411-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1977-01-04 US disclosed